Helicore Biopharma Funding: $65M Raised, Series A (2025)
Helicore Biopharma is a Biotech company based in San Mateo, California. It has raised $65M in total funding. Latest round: Series A.
Helicore Biopharma funding overview
Helicore Biopharma is a Biotech company based in San Mateo, California. Helicore Biopharma has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2025. The round record for Helicore Biopharma runs through 2025; nothing later has been disclosed. Investors on record include Versant Ventures, OrbiMed, Longitude Capital, Wellington Management. 4 distinct backers are named across the disclosed rounds.
Helicore Biopharma has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Helicore Biopharma?
Versant Ventures, OrbiMed, Longitude Capital, Wellington Management are named among the investors backing Helicore Biopharma.
What was the latest Helicore Biopharma funding round?
The most recent disclosed round is a Series A, announced in January 2025.
Where is Helicore Biopharma based?
Helicore Biopharma is based in San Mateo, California.
What sector does Helicore Biopharma operate in?
Helicore Biopharma is tracked under Biotech from San Mateo, California, with $65M in disclosed funding.
When did Helicore Biopharma last raise?
The last disclosed Helicore Biopharma round closed in January 2025 at Series A.
We update the Helicore Biopharma record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in San Mateo and their backers are listed below.
